HF
WGSWW

HRT Financial’s GeneDx Holdings Warrant WGSWW Stock Holding History

HRT Financial’s Portfolio WGSWW Stock Details WGSWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-26,155
Closed – – 3223
2024
Q2 		$0 Buy
+26,155
New +$892 ﹤0.01% 3211
2022
Q4 		– Sell
-20,381
Closed -$4K – 3242
2022
Q3 		$4K Sell
20,381
-9,657
-32% -$2.71K ﹤0.01% 2612
2022
Q2 		$9K Sell
30,038
-3,289
-10% -$1.34K ﹤0.01% 2696
2022
Q1 		$22K Hold
33,327
– – ﹤0.01% 2819
2021
Q4 		$32K Sell
33,327
-2,929
-8% -$5.76K ﹤0.01% 2898
2021
Q3 		$76K Buy
+36,256
New +$119K ﹤0.01% 2974

Other funds holding WGSWW

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

HRT Financial's WGSWW Position: Q3 2024 in Review

HRT Financial sold out of GeneDx Holdings Warrant (WGSWW) in Q3 2024, closing a stake of 26,155 shares.

HRT Financial first reported a position in WGSWW in Q3 2021 and held it in 6 quarters. The position peaked at $76K in Q3 2021. 17 funds tracked by Wall St. Rank hold WGSWW as of Q3 2024.

  • HRT Financial reported no remaining GeneDx Holdings Warrant position as of Q3 2024 after selling out during the quarter.
  • HRT Financial sold 26,155 GeneDx Holdings Warrant shares in Q3 2024.
  • HRT Financial first reported a position in GeneDx Holdings Warrant in Q3 2021 and held it in 6 quarters.
  • HRT Financial's GeneDx Holdings Warrant position peaked at $76K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.